Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Portable Device Developed for Cancer Detection

By LabMedica International staff writers
Posted on 13 Sep 2011
A hand held low-cost device is being developed to diagnose cancer especially for limited-resource settings. More...


The analyzer is operated using mobile electronic devices and performs genetic analysis on micro-ribonucleic acids (miRNAs) which are single-stranded molecules that regulate genes. Changes in certain miRNAs and other genetic marker have been linked to cancer and other health-related issues.

Scientists at Michigan State University (MSU; East Lansing, MI, USA) have developed the genetic analyzer called the Gene-Z which has the capability to screen for established markers of cancer very inexpensively in the field. As it is a hand-held device operated by a solar charged battery, it is particularly useful in limited-resource settings found in the developing world. In addition to cancer detection, the Gene-Z device also is being developed to diagnose routine tuberculosis (TB) and drug-resistant TB, determine human immunodeficiency virus (HIV) levels during treatment and monitor overall antibiotic resistance.

The Gene-Z has been tested using an iPod Touch (Apple Inc., Cupertino, CA, USA) or Android-based tablets (Open Handset Alliance; Mountain View, CA, USA). Syed Hashsham, PhD, a professor at MSU collaborated with Reza Nassiri, MD, PhD, director of MSU's Institute of International Health, to establish connections with physicians worldwide. Prof. Hashsham said, "Gene-Z has the capability to screen for established markers of cancer at extremely low costs in the field, because it is a hand-held device operated by a battery and chargeable by solar energy, it is extremely useful in limited-resource settings."

Prof. Nassiri added, "Until now, little effort has been concentrated on moving cancer detection to global health settings in resource-poor countries. Early cancer detection in these countries may lead to affordable management of cancers with the aid of new screening and diagnostic technologies that can overcome global health care disparities." The Gene-Z device was presented at the US National Institutes of Health's Cancer Detection and Diagnostics Conference, which took place August 22-23, 2011, in Bethesda (MD, USA).

Related Links:
Michigan State University
Apple Inc.
Open Handset Alliance


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Hybrid Pipette
SWITCH
Human Estradiol Assay
Human Estradiol CLIA Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.